Valuation: Abbott Laboratories

Market Cap 179B 160B 148B 134B 251B 17,034B 255B 1,781B 705B 8,925B 673B 659B 28,137B P/E 2026 *
34x
P/E 2027 * 24.9x
Enterprise Value 204B 182B 168B 152B 285B 19,361B 290B 2,025B 802B 10,144B 765B 749B 31,980B EV / Sales 2026 *
4.08x
EV / Sales 2027 * 3.75x
Free-Float
86.16%
Yield 2026 *
2.48%
Yield 2027 * 2.65%
1 day+1.16%
1 week-1.13%
Current month+4.93%
1 month+0.20%
3 months+2.93%
6 months+12.13%
Current year-17.23%
1 week 97.67
Extreme 97.67
106.35
1 month 95.06
Extreme 95.06
106.35
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

333 0.0000%
9/30/26 Free

Director

318 0.0000%
9/30/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%-1.13%-17.92%+8.27% 179B
+0.02%+4.24%-19.82%+16.53% 118B
-1.22%+0.70%+1.27%+31.80% 117B
+2.29%+17.36%-41.94%+9.49% 93.26B
-2.21%-2.91%+0.74%+75.30% 63.16B
-1.06%+1.75%+13.50%+80.00% 55.68B
-0.75%+3.73%+6.64%-22.28% 54.18B
-1.13%+0.00%-12.25%+31.02% 44.15B
+0.17%+5.85%-4.92%-10.64% 33.95B
-2.26%-5.20% - - 29.91B
Average -0.50%+2.72%-8.30%+24.39% 78.83B
Weighted average by Cap. -0.09%+2.77%-11.69%+22.47%

Financials

2026 *2027 *
Net sales 49.96B 44.61B 41.21B 37.35B 69.87B 4,742B 71.03B 496B 196B 2,485B 187B 183B 7,833B 53.55B 47.82B 44.18B 40.03B 74.9B 5,084B 76.14B 532B 210B 2,663B 201B 197B 8,397B
Net income 5.69B 5.08B 4.69B 4.25B 7.96B 540B 8.09B 56.48B 22.36B 283B 21.35B 20.9B 892B 7.68B 6.86B 6.33B 5.74B 10.74B 729B 10.92B 76.22B 30.18B 382B 28.81B 28.2B 1,204B
Net Debt 24.51B 21.89B 20.22B 18.32B 34.28B 2,326B 34.84B 243B 96.32B 1,219B 91.97B 90.02B 3,843B 21.21B 18.94B 17.5B 15.86B 29.67B 2,014B 30.16B 211B 83.37B 1,055B 79.61B 77.92B 3,326B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-23 $103.70 +1.16% 10,296,890
26-10-22 $102.51 +1.99% 10,661,558
26-10-21 $100.51 -1.89% 22,909,735
26-10-20 $102.45 -1.55% 13,854,369
26-10-19 $104.06 -0.79% 8,044,999
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
103.70USD
Average target price
118.52USD
Spread / Average Target
+14.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories